Monday, November 23, 2009

Multiple Sclerosis Home>
Multiple Sclerosis News>
FDA approves Extavia for multiple sclerosis

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

FDA approves Extavia for multiple sclerosis

(Puget Sound Business Journal) UPDATED 2009-08-17

The U.S. Food and Drug Administration has approved a new medication called Extavia for the treatment of multiple sclerosis (MS). Extavia is designed to help MS patients manage their disease by reducing the frequency of episodes of neurological dysfunction that characterize the condition. The drug's maker, Novartis, says it expect Extavia to be available in the fall of this year. Read full story >

See all Multiple Sclerosis News

Related: Extavia

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MultipleSclerosisCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.